Docusate Oral 10 mg/mL Oral Syringe — Class I drug recall D-0219-2017
Terminated recall by US Compounding Inc, reported 2016-12-28, distributed in TX. Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia
| Recall number | D-0219-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | US Compounding Inc, Conway, AR, United States |
| Recall initiated | 2016-07-25 |
| Classified | 2016-12-22 |
| Reported by FDA | 2016-12-28 |
| Terminated | 2017-04-06 |
| Distributed | TX |
| Quantity | 10,665 syringes |
| Reason classes | microbial contamination, sterility |
| Pathogens | burkholderia |
| NDC | 62295-0601-01, 62295-0601-02, 62295-0601-05 |
Product
Docusate Oral 10 mg/mL Oral Syringe, packaged in a) 1 mL (62295-0601-01), b) 2 mL ( 62295-0601-02), and c) 5 mL syringes (62295-0601-05), US Compounding, Conway, AR
Reason for recall
Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0219-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.